Caricamento...

Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy

BACKGROUND: There is legitimate concern that minority drug-resistant mutants may be selected during the initial HIV-1 RNA decay phase following antiretroviral therapy initiation, thus undermining efficacy of treatment. The goal of this study was to characterize viral resistance emergence and address...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Noguera-Julian, Marc, Casadellà, Maria, Pou, Christian, Rodríguez, Cristina, Pérez-Álvarez, Susana, Puig, Jordi, Clotet, Bonaventura, Paredes, Roger
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867623/
https://ncbi.nlm.nih.gov/pubmed/24304606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-10-350
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !